ESC 365 - Risk of dementia in patients treated with non-vitamin k antagonist oral anticoagulant or warfarin for nonvalvular atrial fibrillation

ESC Premium Access

Risk of dementia in patients treated with non-vitamin k antagonist oral anticoagulant or warfarin for nonvalvular atrial fibrillation

Session: Challenges in the management of atrial fibrillation

Topic: Clinical

Speaker: Doctor D. Kim (Seoul, KR)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Daehoon Kim

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))

2 presentations

1 follower

4 more presentations in this session

State of the Art - Hot topics in stroke prevention in atrial fibrillation

Speaker: Professor G. Lip (Liverpool, GB)

Utilization of percutaneous left atrial appendage closure in patients with atrial fibrillation in the United States: analysis from national inpatient sample 2016.

Speaker: Doctor L. Wu (Greenville, US)

Clinical outcomes after catheter ablation for atrial fibrillation in elderly patients: a French nationwide cohort study

Speaker: Professor L. Fauchier (Tours, FR)

Widening the indications for atrial fibrillation ablation - Efficacy and safety concerns.

Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE)

Access the full session

Challenges in the management of atrial fibrillation

Speakers: Doctor D. Kim, Professor G. Lip, Doctor L. Wu, Professor L. Fauchier, Professor C. Blomstrom-Lundqvist

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources